Skip to main content
Back to Valor Equity Partners

Valor Equity Partners's Biotechnology Portfolio

Browse 7 Biotechnology companies funded by Valor Equity Partners. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
7
Total Funding in Biotechnology
$365.9M

Biotechnology Portfolio Companies (7)

Export
Artificial Intelligence (AI)BiopharmaBiotechnologyNeurosciencePrecision Medicine

Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.

Los Altos, United States
March 2026
$120.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyClinical TrialsHealth Care

NewLimit is a biotech company developing epigenetic therapies to extend human healthspan by reprogramming aging cells.

South San Francisco, United States
October 2025
$45.0M
Convertible Note

Founder Contacts

19,000+ verified contacts

AnalyticsArtificial Intelligence (AI)Big DataBiotechnologyHealth CareInformation ServicesWater

A wastewater data platform delivering population-level health insights

Cambridge, United States
June 2025
$13.4M
Series A

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife ScienceMedicalTherapeutics

Evozyne is a generative AI company that focuses on therapeutic discovery and drug development.

Chicago, United States
September 2023
$81.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyPetPharmaceuticalVeterinary

Loyal is a clinical-stage veterinary medicine company dedicated to extending the healthy lifespan of senior dogs.

San Francisco, United States
February 2026
$100.0M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyFood and BeverageFood ProcessingMachine LearningSustainability

Bettani creates plant-based ingredients and products using data-driven technology and culinary expertise.

Berkeley, United States
October 2025
$6.5M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalNeuroscienceRobotics

Neuralink is a neurotechnology company that focuses on developing brain-computer interfaces designed to treat neurological disorders.

Fremont, United States
July 2025
Series Unknown

Founder Contacts

19,000+ verified contacts

Explore Valor Equity Partners's Full Portfolio

View all companies funded by Valor Equity Partners across every industry and funding stage.

View Full Valor Equity Partners Portfolio